ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of December

December 26, 2014

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006

In Brief: NCI Providing Information On Levamisole To Patients; Macdonald Jins Temple, Salick

July 21, 1989

ACS Urges Bush To Increase NCI Budget.

January 19, 2007

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

November 2, 1990

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

August 29, 2003